Kayyem Jon Faiz

Inhibrx Biosciences, Inc. · Director

Kayyem Jon Faiz is listed in public filings as director. This Kayyem Jon Faiz insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Inhibrx Biosciences, Inc. (INBX), and Biodesix, Inc. (BDSX). Investors use Kayyem Jon Faiz's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Inhibrx Biosciences, Inc.INBX$1.4M15k sharesGrant / ExerciseJun 3, 2026$1.4M15k shares$95.22--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Biodesix, Inc.BDSX--5.4k sharesGrant / ExerciseJan 2, 2026Disclosure amount unavailable5.4k shares----
Biodesix, Inc.BDSX$41k6.4k sharesGrant / ExerciseJan 2, 2026$41.0K6.4k shares$6.46--
Inhibrx Biosciences, Inc.INBX$194k15k sharesGrant / ExerciseMay 28, 2025$193.7K15k shares$12.91--
Biodesix, Inc.BDSX--68.6k sharesGrant / ExerciseMay 20, 2025Disclosure amount unavailable68.6k shares----
Biodesix, Inc.BDSX$11k42k sharesGrant / ExerciseMay 20, 2025$11.4K42k shares$0.2708--
Inhibrx Biosciences, Inc.INBX--419.4k sharesGrant / ExerciseMar 27, 2025Disclosure amount unavailable90k shares----
Inhibrx Biosciences, Inc.INBX--250k sharesGrant / ExerciseDec 16, 2024Disclosure amount unavailable250k shares----
Inhibrx Biosciences, Inc.INBX--509.4k sharesGrant / ExerciseDec 16, 2024Disclosure amount unavailable500k shares----
Inhibrx Biosciences, Inc.INBX--1M sharesGrant / ExerciseDec 6, 2024Disclosure amount unavailable52k shares----
Inhibrx Biosciences, Inc.INBX$991k69.8k sharesBuyNov 20, 2024$266.1K18.8k shares$14.19--
Inhibrx Biosciences, Inc.INBX$727k51.1k sharesBuyNov 19, 2024$495.7K34.8k shares$14.23--